Anlon Healthcare

Anlon Healthcare EBIT per Share

The EBIT per Share of Anlon Healthcare (AHCL.NS) as of Nov 16, 2026 is 0.87 INR. In the previous year, EBIT per Share was 0.58 INR — a change of 51.39% (higher).

EBIT per Share

0.87INR

YoY

51.39%

Last updated:

EBIT per Share of Anlon Healthcare is 2026 0.87 INR. EBIT per Share of Anlon Healthcare was 2025 0.58 INR. It decreases by 51.39% higher compared to the previous year.

The Anlon Healthcare EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2022
0.67 INR
Jan 1, 2023
0.20 INR
Jan 1, 2024
0.26 INR
Jan 1, 2025
0.58 INR
Jan 1, 2026
0.87 INR
The Anlon Healthcare EBIT per Share history
YEAREBIT per ShareYoY
0.87INR+51.39%
0.58INR+120.79%
0.26INR+27.20%
0.20INR-69.57%
0.67INR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Anlon Healthcare Stock analysis

What does Anlon Healthcare do? Anlon Healthcare Ltd. generates revenue through the production and sale of pharmaceutical intermediates, active pharmaceutical ingredients (APIs), nutraceutical APIs, and ingredients for personal care and veterinary applications. Its product portfolio includes 3-(1-cyanoethyl) benzoic acid (CEBA), ketoprofen ethyl ester (KEE), Dex-Ketoprofen, Loxoprofen Acid, Ketoprofen, Silodosin, Omeprazole, L-Arginine, Piroctone olamine, Ticagrelor, and other specialized compounds. The company targets pharmaceutical manufacturers, nutraceutical producers, and personal care and veterinary product developers as its primary customers, serving the broader healthcare and wellness industry segments. The business model focuses on supplying high-quality chemical compounds used in the formulation of medicines and health-related products. Anlon Healthcare Ltd. leverages its expertise in chemical synthesis to deliver tailored solutions for clients in the pharmaceutical sector, ensuring compliance with industry standards. Its product range supports diverse applications, from human medicine to veterinary care and personal care products, enabling it to serve multiple market segments with a single production infrastructure. Revenue streams are derived from direct sales of its chemical products to manufacturers across pharmaceutical, nutraceutical, personal care, and veterinary industries. The company's offerings are designed to meet the specific needs of these sectors, with products like Omeprazole for gastrointestinal treatments and Ticagrelor for cardiovascular care. By providing essential raw materials, Anlon Healthcare Ltd. positions itself as a critical supplier within the healthcare supply chain. Anlon Healthcare is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Anlon Healthcare stock

EBIT per Share of Anlon Healthcare is 0.87 INR in 2026.

EBIT per Share of Anlon Healthcare changed from 0.58 INR to 0.87 INR, representing a 51.39% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share Anlon Healthcare since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Anlon Healthcare

All Key Metrics — Anlon Healthcare